Engineered bacteria detect tumor DNA
Science · 11.08.2023 · 381 (6658) · 682-686
DOI: 10.1126/science.adf3974 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 11.08.2023. Verfasst von Robert M Cooper und 15 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA, Neoplasm, Acinetobacter, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Synthetic biology has developed sophisticated cellular biosensors to detect and respond to human disease. However, biosensors have not yet been engineered to detect specific extracellular DNA sequences and mutations. Here, we engineered naturally competent Acinetobacter baylyi to detect donor DNA from the genomes of colorectal cancer (CRC) cells, organoids, and tumors. We characterized the functionality of the biosensors in vitro with coculture assays and then validated them in vivo with sensor bacteria delivered to mice harboring colorectal tumors. We observed horizontal gene transfer from the tumor to the sensor bacteria in our mouse model of CRC. This cellular assay for targeted, CRISPR-discriminated horizontal gene transfer (CATCH) enables the biodetection of specific cell-free DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA.
- Precision Cancer Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.
- Adelaide Medical School, University of Adelaide, Adelaide, SA 5000, Australia.
- Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.
- Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
- Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Robert M Cooper, Josephine A Wright, Jia Q Ng, Nobumi Suzuki, Young K Lee, Mari Ichinose, Georgette Radford, Feargal J Ryan, Elaine M Thomas, Laura Vrbanac, Rob Knight, Susan L Woods, Daniel L Worthley, Jeff Hasty
Förderung
- NCI NIH HHS
Zitieren
APA
Cooper, R. M., Wright, J. A., Ng, J. Q., Goyne, J. M., Suzuki, N., Lee, Y. K., Ichinose, M., Radford, G., Ryan, F. J., Kumar, S., Thomas, E. M., Vrbanac, L., Knight, R., Woods, S. L., Worthley, D. L., & Hasty, J. (2023). Engineered bacteria detect tumor DNA. Science, 381(6658), 682-686. https://doi.org/10.1126/science.adf3974
Vancouver
Cooper RM, Wright JA, Ng JQ, Goyne JM, Suzuki N, Lee YK, et al. Engineered bacteria detect tumor DNA. Science. 2023;381(6658):682-686. doi:10.1126/science.adf3974
BibTeX
@article{Cooper2023,
author = {Cooper, Robert M and Wright, Josephine A and Ng, Jia Q and Goyne, Jarrad M and Suzuki, Nobumi and Lee, Young K and Ichinose, Mari and Radford, Georgette and Ryan, Feargal J and Kumar, Shalni and Thomas, Elaine M and Vrbanac, Laura and Knight, Rob and Woods, Susan L and Worthley, Daniel L and Hasty, Jeff},
title = {Engineered bacteria detect tumor DNA},
journal = {Science},
year = {2023},
volume = {381},
number = {6658},
pages = {682--686},
doi = {10.1126/science.adf3974}
}
EUVIMED